Molecular Diagnostics uses Polymerase Chain Reaction (PCR) technology, a Nobel-prize winning discovery.
This is a simple yet elegant means by which virtually unlimited copies of genetic material can be made in a test tube.
Through our long-term commitment to helping laboratories improve the products and services they offer, Roche Diagnostics Australia distribute reagents and instruments used for early, rapid and accurate disease diagnosis.
We continue to build on this commitment through the development of products using PCR technology.
Since acquiring the rights to this technology in 1991, we have made PCR the leading DNA technology in the world, enabling improved management of patient outcomes.
PCR’s exquisite sensitivity makes it possible to diagnose infectious agents earlier and to monitor disease progression and response to therapy.
New applications of the technique will allow it to predict disease predisposition and to individualise patient therapy, all resulting in earlier treatment and improved patient care.